Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 818261, 13 pages
http://dx.doi.org/10.1155/2012/818261
Research Article

Terpinen-4-ol Induces Apoptosis in Human Nonsmall Cell Lung Cancer In Vitro and In Vivo

1Department of Dermatology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan
2Department of Child Care, College of Humanities and Social Sciences, Southern Taiwan University, Tainan 71005, Taiwan
3Institute of Biomedical Sciences, College of Life Science, National Chung Hsing University, Taichung 40227, Taiwan
4Agricultural Research Institute, Council of Agriculture Executive, Yuan 10014, Taiwan
5Department of Internal Medicine, Division of Chest Medicine, Taichung Veterans General Hospital, Taichung 40705, Taiwan
6Department of Medical Education and Research, Taichung-Veterans General Hospital, Taichung 40705, Taiwan
7Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan

Received 18 February 2011; Accepted 18 April 2011

Academic Editor: José L. Ríos

Copyright © 2012 Chieh-Shan Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Parkin, F. Bray, J. Ferlay, and P. Pisani, “Estimating the world cancer burden: globocan 2000,” International Journal of Cancer, vol. 94, no. 2, pp. 153–156, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. P. J. Souquet, F. Chauvin, J. P. Boissel et al., “Polychemotherapy in advanced non-small cell lung cancer: a meta-analysis,” Lancet, vol. 342, no. 8862, pp. 19–21, 1993. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Gershenzon and N. Dudareva, “The function of terpene natural products in the natural world,” Nature Chemical Biology, vol. 3, no. 7, pp. 408–414, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. K. H. Wagner and I. Elmadfa, “Biological relevance of terpenoids: overview focusing on mono-, di- and tetraterpenes,” Annals of Nutrition and Metabolism, vol. 47, no. 3-4, pp. 95–106, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. S. S. Clark, S. M. Perman, M. B. Sahin, G. J. Jenkins, and J. A. Elegbede, “Antileukemia activity of perillyl alcohol (POH): uncoupling apoptosis from G0/G1 arrest suggests that the primary effect of POH on Bcr/Abl-transformed cells is to induce growth arrest,” Leukemia, vol. 16, no. 2, pp. 213–222, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Yeruva, K. J. Pierre, A. Elegbede, R. C. Wang, and S. W. Carper, “Perillyl alcohol and perillic acid induced cell cycle arrest and apoptosis in non small cell lung cancer cells,” Cancer Letters, vol. 257, no. 2, pp. 216–226, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. C. O. Da Fonseca, M. Masini, D. Futuro, R. Caetano, C. Rocha Gattass, and T. Quirico-Santos, “Anaplastic oligodendroglioma responding favorably to intranasal delivery of perillyl alcohol: a case report and literature review,” Surgical Neurology, vol. 66, no. 6, pp. 611–615, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. C. O. da Fonseca, G. Schwartsmann, J. Fischer et al., “Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas,” Surgical Neurology, vol. 70, no. 3, pp. 259–266, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Astani, J. Reichling, and P. Schnitzler, “Comparative study on the antiviral activity of selected monoterpenes derived from essential oils,” Phytotherapy Research, vol. 24, no. 5, pp. 673–679, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. J. D. Cha, M. R. Jeong, S. I. Jeong et al., “Chemical composition and antimicrobial activity of the essential oil of Cryptomeria japonica,” Phytotherapy Research, vol. 21, no. 3, pp. 295–299, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Barra, V. Coroneo, S. Dessi, P. Cabras, and A. Angioni, “Characterization of the volatile constituents in the essential oil of Pistacia lentiscus l. from different origins and its antifungal and antioxidant activity,” Journal of Agricultural and Food Chemistry, vol. 55, no. 17, pp. 7093–7098, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. D. E. Wedge, N. Tabanca, B. J. Sampson et al., “Antifungal and insecticidal activity of two juniperus essential oils,” Natural Product Communications, vol. 4, no. 1, pp. 123–127, 2009. View at Google Scholar · View at Scopus
  13. B. Zúñiga, P. Guevara-Fefer, J. Herrera et al., “Chemical composition and anti-inflammatory activity of the volatile fractions from the bark of eight Mexican Bursera species,” Planta Medica, vol. 71, no. 9, pp. 825–828, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. S. J. Greay, D. J. Ireland, H. T. Kissick et al., “Induction of necrosis and cell cycle arrest in murine cancer cell lines by Melaleuca alternifolia (tea tree) oil and terpinen-4-ol,” Cancer Chemotherapy and Pharmacology, vol. 65, no. 5, pp. 877–888, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Calcabrini, A. Stringaro, L. Toccacieli et al., “Terpinen-4-ol, the main component of Melaleuca alternifolia (Tea Tree) oil Inhibits the in Vitro growth of human melanoma cells,” Journal of Investigative Dermatology, vol. 122, no. 2, pp. 349–360, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. G. C. Chang, C. T. R. Yu, C. H. Tsai et al., “An epidermal growth factor inhibitor, Gefitinib, induces apoptosis through a p53-dependent upregulation of pro-apoptotic molecules and downregulation of anti-apoptotic molecules in human lung adenocarcinoma A549 cells,” European Journal of Pharmacology, vol. 600, no. 1–3, pp. 37–44, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Mondello, F. De Bernardis, A. Girolamo, A. Cassone, and G. Salvatore, “In vivo activity of terpinen-4-ol, the main bioactive component of Melaleuca alternifolia Cheel (tea tree) oil against azole-susceptible and -resistant human pathogenic Candida species,” BMC Infectious Diseases, vol. 6, article no. 158, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. A. H. Wyllie, J. F. R. Kerr, and A. R. Currie, “Cell death: the significance of apoptosis,” International Review of Cytology, vol. 68, pp. 251–306, 1980. View at Google Scholar · View at Scopus
  19. P. Li, D. Nijhawan, I. Budihardjo et al., “Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade,” Cell, vol. 91, no. 4, pp. 479–489, 1997. View at Google Scholar · View at Scopus
  20. J. K. Brunelle and A. Letai, “Control of mitochondrial apoptosis by the Bcl-2 family,” Journal of Cell Science, vol. 122, no. 4, pp. 437–441, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. L. Yang and X. M. Li, “The IAP family: endogenous caspase inhibitors with multiple biological activities,” Cell Research, vol. 10, no. 3, pp. 169–177, 2000. View at Google Scholar · View at Scopus
  22. M. B. Kastan, O. Onyekwere, D. Sidransky, B. Vogelstein, and R. W. Craig, “Participation of p53 protein in the cellular response to DNA damage,” Cancer Research, vol. 51, no. 23, pp. 6304–6311, 1991. View at Google Scholar · View at Scopus
  23. A. J. Levine, “p53, the cellular gatekeeper for growth and division,” Cell, vol. 88, no. 3, pp. 323–331, 1997. View at Publisher · View at Google Scholar · View at Scopus
  24. N. A. Thornberry and Y. Lazebnik, “Caspases: enemies within,” Science, vol. 281, no. 5381, pp. 1312–1316, 1998. View at Google Scholar · View at Scopus
  25. C. Kitanaka and Y. Kuchino, “Caspase-independent programmed cell death with necrotic morphology,” Cell Death and Differentiation, vol. 6, no. 6, pp. 508–515, 1999. View at Google Scholar · View at Scopus
  26. S. H. Kaufmann and G. J. Gores, “Apoptosis in cancer: cause and cure,” BioEssays, vol. 22, no. 11, pp. 1007–1017, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. G. T. Williams, “Programmed cell death: apoptosis and oncogenesis,” Cell, vol. 65, no. 7, pp. 1097–1098, 1991. View at Google Scholar · View at Scopus
  28. S. C. Lim, J. E. Choi, H. S. Kang, and H. Si, “Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma,” International Journal of Cancer, vol. 126, no. 7, pp. 1582–1595, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Leake, “The cell cycle and regulation of cancer cell growth,” Annals of the New York Academy of Sciences, vol. 784, pp. 252–262, 1996. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Xiong, G. J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach, “p21 is a universal inhibitor of cyclin kinases,” Nature, vol. 366, no. 6456, pp. 701–704, 1993. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Polyak, J. Y. Kato, M. J. Solomon et al., “p27(Kip1), a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest,” Genes and Development, vol. 8, no. 1, pp. 9–22, 1994. View at Google Scholar · View at Scopus
  32. C. Laronga, H. Y. Yang, C. Neal, and M. H. Lee, “Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression,” Journal of Biological Chemistry, vol. 275, no. 30, pp. 23106–23112, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Liu, J. J. Stanton, Z. Wu, and H. Piwnica-Worms, “The human Myt1 kinase preferentially phosphorylates Cdc2 on threonine 14 and localizes to the endoplasmic reticulum and Golgi complex,” Molecular and Cellular Biology, vol. 17, no. 2, pp. 571–583, 1997. View at Google Scholar · View at Scopus
  34. M. Motwani, X. K. Li, G. K. Schwartz et al., “The in vivo effect of bryostatin-1 on paclitaxel-induced tumor growth, mitotic entry, and blood flow,” Clinical Cancer Research, vol. 6, no. 4, pp. 1498–1507, 2000. View at Google Scholar · View at Scopus